SNTI vs SONY
Senti Biosciences Inc (SNTI) versus SONY (SONY) — a side-by-side from cached financials, not a winner call.
Senti Biosciences Inc (SNTI) is a biotechnology company listed on NASDAQ.
SONY (SONY) common stock.
Latest reported SNTI revenue for 2026-06-30 was $33.0K. Net income was -$17.0M. SNTI currently screens at market cap $29.6M.
SONY does not have a complete income-statement cache yet.
SNTI currently screens at market cap $29.6M. SONY currently screens at market cap $0.
Not investment advice. Open the SNTI and SONY stock pages for the full models.
Not investment advice.